Added to YB: 2025-07-22
Pitch date: 2025-07-20
CUPID.NS [bullish]
Cupid Limited
+6.65%
current return
Author Info
No bio for this author
Company Info
Cupid Limited designs, manufactures, markets, and exports male and female condoms in India. The company offers water based lubricant jellies; in vitro diagnostic kits, including rapid diagnostic, viral transport medium, typhoid antibody, syphilis antibody, HIV 1 and 2 kit antibody, dengue IgG/IgM Antibody, malaria Pf-Pv and Pf-PAN antigen, hepatitis B (HbsAg) antigen, hepatitis C (HCV) antibody, pregnancy hCG detection, LH ovulation rapid, and dengue NS1 test; and deodorant and pocket perfumes.
Market Cap
INR 39.4B
Pitch Price
INR 148.20
Price Target
N/A
Dividend
N/A
Sector
Personal Care Products
Category
growth
This ‘Taboo’ Stock Is Quietly Building a ₹400 Cr Global Wellness Empire - Cupid Limited
CUPID.NS: India's WHO-prequalified condom maker diversifying into IVD kits & FMCG retail. Growing from 1000 to 175K outlets by FY26 targeting ₹125Cr B2C sales. Expanding capacity 1.5x at new Palava plant. FY24: ₹171Cr revenue (+7.5%), ₹40Cr profit (+26%), 29% EBITDA margin. Post-expansion target: ₹400Cr topline, ₹100Cr EBITDA.
Read full article (7 min)